Company broadens service offerings and strengthens network by purchasing Catalent's Center-of-Excellence for Small Molecule Analytical Services facility in North Carolina MINNEAPOLIS, MN ...

MINNEAPOLIS, September 26, 2024 (Newswire.com) - Pace ® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO) and a Division of Pace ®, a Science and Technology Company, ...

Fintel reports that on September 24, 2024, Baird downgraded their outlook for Catalent (NYSE:CTLT) from Outperform to Neutral ...

Robert W. Baird analyst Eric Coldwell downgraded the rating on Catalent (CTLT – Research Report) to a Hold today, setting a price target of $63.50. Eric Coldwell has given his Hold rating due to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...